Not Everyone Gets Side Effects From Wegovy — but Here's How to Tell What's Happening

Why no side effects is a completely valid experience

Wegovy (semaglutide) affects appetite, gastric emptying and blood-sugar signalling, but the degree to which any individual feels those changes varies considerably. Clinical trials like STEP 1, published in the New England Journal of Medicine, enrolled thousands of participants and found that while gastrointestinal effects were common at a population level, responses across individuals differed a great deal. Some participants on 2.4mg reported mild or no GI symptoms throughout.

Dose matters here too. The titration schedule (starting low and stepping up roughly every four weeks) is designed partly to let your body acclimatise. People who feel nothing at 0.25mg or 0.5mg are not unusual; the question is how they respond as the dose increases.

There is also a practical element to timing. If you happen to start Wegovy at a busy point in the month (say, just before a holiday or in a hectic work week) mild symptoms can go unnoticed or be attributed to other things. The absence of a dramatic reaction does not mean semaglutide is inactive. The NHS patient guide on semaglutide is clear that tolerability varies and that not everyone will experience the listed effects.

If you are genuinely symptom-free, you can read more about what that means and why it happens on our page covering why some people have no side effects on Wegovy. Keep injecting on schedule and stay in contact with your clinical team.

The side effects that do affect many people, and why they usually settle

The honest picture, drawn from the approved SmPC and NHS guidance, is that most side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, reflux and burping are the ones that come up most often. Fatigue and headache appear too, particularly after a dose increase.

These tend to be most noticeable in the first week or two at a new dose, then fade. Eating smaller portions, avoiding fatty or heavily spiced food, staying well hydrated and not lying down immediately after eating can all reduce the intensity. If you find a particular side effect from Wegovy more disruptive than manageable, that is a conversation for your prescriber, slowing the titration is sometimes the right call, and it is better to flag it than push through.

For a more detailed breakdown of what to expect at each stage, the complete guide to Wegovy side effects covers the profile by frequency and severity, including rarer reactions. The page on severe side effects focuses on the end of the spectrum that needs real attention.

The key point: if you have no symptoms now, you may develop some when your dose increases. Understanding the full range of side effects from taking Wegovy helps you avoid unnecessary worry, and helps you recognise the things that are genuinely not.

When to get medical help, and what cannot wait

Most Wegovy side effects are inconvenient rather than dangerous. A handful are not. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 medicines. The warning symptom is severe, persistent stomach pain that radiates to the back, with or without vomiting. Do not manage this at home. Go to A&E or call 999 if the pain is severe.

Other situations that need prompt medical attention: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rash spreading quickly); gallbladder symptoms (sharp pain in the upper right abdomen, especially after eating fatty food); significant dehydration from severe or prolonged vomiting or diarrhoea; and any sudden changes in vision if you have diabetes.

Low mood or thoughts of self-harm are listed in Wegovy's prescribing information as something to report to a clinician promptly. If you or someone you know is experiencing this, contact your prescriber, GP or call 111.

If you experience something unexpected and are unsure whether it is medicine-related, the MHRA's Yellow Card scheme lets patients report suspected side effects directly. It takes a few minutes and contributes to post-market safety monitoring for everyone using these medicines. You can also reach the nume team seven days a week if you have a question about something you're experiencing.

The decision in front of you: continue, adjust, or get reviewed

If you are on Wegovy and feeling fine, the decision is straightforward: carry on, keep your prescriber informed at each review, and stay alert to the warning signs above. That is not complacency, it is appropriate self-monitoring.

If you are still weighing up whether Wegovy is the right option, the side-effect profile is one factor among several. Eligibility, your starting dose, the titration plan and any existing health conditions all shape how treatment is structured for you. Our prescribers at nume go through all of this during the consultation, not as a tick-box exercise, but as a genuine clinical assessment of whether Wegovy suits you and how to manage it if it does.

You can also read the full Wegovy overview to understand the medicine in context, or explore all the treatment options we offer if you want to compare before committing to anything. The consultation itself is free, and there is no obligation to proceed.

To check whether you are clinically suitable and to talk through what to expect, check your eligibility with our prescribers, it is the same-day process, and someone real reads your answers.